心血管病防治知识(下半月)
心血管病防治知識(下半月)
심혈관병방치지식(하반월)
XINXUEGUANBING FANGZHI ZHISHI
2014年
11期
72-74
,共3页
冠心病%慢性心力衰竭%室性心律失常%临床治疗
冠心病%慢性心力衰竭%室性心律失常%臨床治療
관심병%만성심력쇠갈%실성심률실상%림상치료
Coronary heart disease%Chronic heart failure%Ventricular arrhythmia%Clinical treatment
目的:讨论在临床中对冠心病慢性心力衰竭患者存在的室性心律失常进行治疗的临床效果。方法选取我院2012年1月-2014年6月收治治疗的冠心病心力衰竭患者100例,随机的把其分成观察组与对照组,其中观察组患者通过胺碘酮进行治疗,而对照组患者选择常规治疗手段进行治疗,对两组患者的临床治疗效果进行对比分析。结果两组患者经过治疗后,对照组患者的治疗总有效率为76.0%,显效率为48.0%;而观察组患者的治疗总有效率为94.0%,显效率为80.0%;两组患者进行对比,观察组患者的临床疗效明显的高于对照组。100例冠心病衰竭患者中,出现室性心律失常的患者为46例,随着左心室内径的逐渐增大,其出现室性心律失常的概率则越高。结论对于冠心病心力衰竭来说,出现室性心律失常的概率较高,应用胺碘酮对其进行治疗,具备着非常显著的效果,在临床中值得推广与应用。
目的:討論在臨床中對冠心病慢性心力衰竭患者存在的室性心律失常進行治療的臨床效果。方法選取我院2012年1月-2014年6月收治治療的冠心病心力衰竭患者100例,隨機的把其分成觀察組與對照組,其中觀察組患者通過胺碘酮進行治療,而對照組患者選擇常規治療手段進行治療,對兩組患者的臨床治療效果進行對比分析。結果兩組患者經過治療後,對照組患者的治療總有效率為76.0%,顯效率為48.0%;而觀察組患者的治療總有效率為94.0%,顯效率為80.0%;兩組患者進行對比,觀察組患者的臨床療效明顯的高于對照組。100例冠心病衰竭患者中,齣現室性心律失常的患者為46例,隨著左心室內徑的逐漸增大,其齣現室性心律失常的概率則越高。結論對于冠心病心力衰竭來說,齣現室性心律失常的概率較高,應用胺碘酮對其進行治療,具備著非常顯著的效果,在臨床中值得推廣與應用。
목적:토론재림상중대관심병만성심력쇠갈환자존재적실성심률실상진행치료적림상효과。방법선취아원2012년1월-2014년6월수치치료적관심병심력쇠갈환자100례,수궤적파기분성관찰조여대조조,기중관찰조환자통과알전동진행치료,이대조조환자선택상규치료수단진행치료,대량조환자적림상치료효과진행대비분석。결과량조환자경과치료후,대조조환자적치료총유효솔위76.0%,현효솔위48.0%;이관찰조환자적치료총유효솔위94.0%,현효솔위80.0%;량조환자진행대비,관찰조환자적림상료효명현적고우대조조。100례관심병쇠갈환자중,출현실성심률실상적환자위46례,수착좌심실내경적축점증대,기출현실성심률실상적개솔칙월고。결론대우관심병심력쇠갈래설,출현실성심률실상적개솔교고,응용알전동대기진행치료,구비착비상현저적효과,재림상중치득추엄여응용。
Objective To investigate the clinical effect of treatment for ventricular arrhythmia in coronary heart disease (CHD) patients with chronic heart failure (CHF). Methods A total of 100 cases of CHD who had CHF and were treated in our hospital between January 2012 and June 2014 were selected and randomly divided into observation group and control group. The observation group was treated with amiodarone, while the control group was treated with conventional methods. The treatment outcomes of the two groups were then compared and analyzed. Results After treatment, the overall response rate and marked response rate for the control group were 76.0% and 48.0%, respectively, versus 94.0% and 80.0% for the observation group. The comparison results showed that the patients in the observation group had significantly better clinical outcomes than those in the control group. Of the 100 CHD patients with CHF, 46 developed ventricular arrhythmia. The risk of developing ventricular arrhythmia rose with increasing left ventricular internal diameter.Conclusion Amiodarone is effective in CHD patients with CHF who are prone to ventricular arrhythmia. Thus, it deserves wide application in clinical practice.